Chronic Nuclear Factor-Kappa B Inhibition Prevents Experimental Aging Nephropathy
Gerontology · 2024
DOI: 10.1159/000540761 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gerontology, 2024. Verfasst von Helena Mendonça Tessaro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Losartan, NF-kappa B, Pyrrolidines, Thiocarbamates. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Introduction
The pathogenesis of aging nephropathy (AN) is yet to be elucidated. Intrarenal angiotensin II (AngII) and activation of the nuclear factor-kappa B (NF-κB) and NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome pathways exert a relevant pathogenic role in the progression of chronic kidney disease. We sought to investigate whether monotherapy with losartan and combined treatment with losartan and the NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) would attenuate experimental AN. Materials and Methods: Forty adult male Munich-Wistar rats were distributed among four groups: 12M (n = 10), untreated 12-month-old rats; 15M (n = 10), untreated 15-month-old rats; 15MLos (n = 8), rats receiving losartan (50 mg/kg/d); and 15MLos+PDTC (n = 8), rats receiving losartan and PDTC (60 mg/kg/d). All treatments were given by mouth from 12 to 15 months of age.
Results
Group 15M exhibited slightly decreased tail-cuff pressure and marked increase in albuminuria, sclerotic glomeruli, cortical collagen-1 deposition and infiltration by myofibroblasts, AngII-positive cells, and proinflammatory M1 macrophages, whereas the amount of anti-inflammatory M2 macrophages was reduced. In addition, the renal abundance of TLR4, nuclear p65, and IL-6 was increased, indicating activation of the NF-κB pathway, without evidence of simultaneous activation of the NLRP3 cascade. Losartan treatment decreased cortical collagen-1 deposition, myofibroblasts, and AngII-positive cells and partially restored renal M2 but had no significant effect on albuminuria, glomerulosclerosis, or NF-κB activation. Combined losartan+PDTC prevented all the observed abnormalities.
Discussion
Simultaneous blockade of renal AngII and inhibition of the NF-κB pathway may represent a novel alternative to limit the decline of renal function with age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo São Paulo, São Paulo, Brazil.
- Laboratory of Transplantation Immunobiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
- Renal Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo São Paulo, São Paulo, Brazil, r.zatz@fm.usp.br.
Zitieren
APA
Tessaro, H. M., Fregnan Zambom, F. F., Foresto-Neto, O., Fim Ribeiro, S. C., Ramos de Sena, C., Avancini Costa Malheiros, D. M., Saraiva Câmara, N. O., Fujihara, C. K., & Zatz, R. (2024). Chronic Nuclear Factor-Kappa B Inhibition Prevents Experimental Aging Nephropathy. Gerontology. https://doi.org/10.1159/000540761
Vancouver
Tessaro HM, Fregnan Zambom FF, Foresto-Neto O, Fim Ribeiro SC, Ramos de Sena C, Avancini Costa Malheiros DM, et al. Chronic Nuclear Factor-Kappa B Inhibition Prevents Experimental Aging Nephropathy. Gerontology. 2024. doi:10.1159/000540761
BibTeX
@article{Tessaro2024,
author = {Tessaro, Helena Mendonça and Fregnan Zambom, Fernanda Florencia and Foresto-Neto, Orestes and Fim Ribeiro, Sara Cristina and Ramos de Sena, Claudia and Avancini Costa Malheiros, Denise Maria and Saraiva Câmara, Niels Olsen and Fujihara, Clarice Kazue and Zatz, Roberto},
title = {Chronic Nuclear Factor-Kappa B Inhibition Prevents Experimental Aging Nephropathy},
journal = {Gerontology},
year = {2024},
doi = {10.1159/000540761}
}
EUVIMED